Biotech & Health

Theranos Wellness Centers Aren’t Using “Nanotainers” At This Time

Comment

A Theranos testing center in Mesa, Arizona has informed me they are not allowed to use Theranos’ proprietary equipment to test for herpes simplex 1, the only test the FDA has so far given Theranos the green light to test on their own technology.

I’m in Arizona visiting family over the holidays and since I’m in the only state currently running tests for Theranos — the blood analysis startup worth just north of $9 billion — I thought I’d take the chance to try its wellness center.

Theranos was the subject of several investigative pieces in the Wall Street Journal claiming that the company was struggling with its blood-test technology. The company later confirmed it was only using one of the 240 tests offered on its site with its own technology – the herpes simplex 1 test.

So there I was at the back of the nearest Walgreens with a Theranos Wellness Center with my mom, ordering a herpes test. I thought to do a couple of other tests I could use as well just to get a sense for how the whole system operates so I ordered a pretty innocuous B12 test and an iron deficiency test with it.

294c123b-6a4d-4676-bc6b-5eabb2bbb3e1

The man at the counter took my paperwork, quickly processed me in the system and walked me back to the testing room where two women dressed in scrubs were waiting for me. One of the women, Dakota, was very good at finding my vein and taking blood intravenously. Then I asked about what Theranos calls “nanotainers” or tiny vials that can give you test results with a single drop of blood.

“Oh you have to order that separately,” she informed me. “We take those intravenously if you bundle a bunch of tests together.”

“So you can’t use the technology on this order because I ordered a few tests together?” I asked. She confirmed that was the case and told me they didn’t get a lot of requests for that particular test on its own.

I asked about the test and both Theranos employees raved about the work they were doing and the technology.

I then informed them I was a journalist and would like to take the test separately to test the technology. They told me I would still need to order it separately. So I went to order it separately.

That’s when things got weird. It took much longer to process this separate order at the counter. I was told it was because they had to manually type in my order on the other end.

Then I walked myself back to the testing center and could overhear one of the women on the phone with management in a panicked voice telling them I was a journalist doing an investigative piece (I wasn’t, just curious as to how it worked).

Dakota opened the door and informed me they could not use the Theranos device at this time to test on me. After a long pause, I asked if she thought that was odd. She said she was surprised and that as far as she knew they could until then because, “That’s what we’ve been told.”

She then asked if I wanted to speak with a Theranos manager to explain why I couldn’t test at this time. I spoke with Chris, the Theranos manager, on the phone who informed me it was about supplies. Okay, but the people with the supplies to administer the test seemed to think I could take it until management said they could not that day.

I reached out to Theranos head of communications Brooke Buchanan for an explanation as well. She’d already been informed I was in the store today. Instead of explaining why I couldn’t test on Theranos technology, I was asked why I chose not to go to the Theranos main office in Palo Alto for a test instead (she’d invited me to come visit after the holiday break).

Testing at the Theranos office and at a Walgreens aren’t mutually exclusive. But it is weird Theranos wanted me to test at headquarters instead of at a Wellness Center. It’s also weird the only test using the nanotainer is unavailable for testing at these centers, even though it has FDA approval.

Theranos claims it does not need FDA approval for its proprietary technology but chooses to gain approval on a voluntary basis before using it to test. However, an FDA document shows the regulatory agency found Theranos in violation of misclassifying the nanotainers and that it considered them an “uncleared medical device.”

Theranos later said it had “addressed and corrected” concerns the FDA had at the time.

Update: Theranos says it has taken a “pause” to seek FDA approval on its technology and that it is not just a company with nanotainer devices, but also uses proprietary chemistries and machinery.

Is it odd only one test has been approved so far and that you can only get it if you order it alone? Is it odd it happens to be something not commonly ordered alone? Either way, you can’t get the test using Theranos technology at this time.

I’d like to hear from readers who have tested on Theranos’ technology using the nanotainers outside of Theranos’ office. If that is you, please contact me at sarah.buhr at TechCrunch dot com

More TechCrunch

When Alex Ewing was a kid growing up in Purcell, Oklahoma, he knew how close he was to home based on which billboards he could see out the car window.…

OneScreen.ai brings startup ads to billboards and NYC’s subway

SpaceX’s massive Starship rocket could take to the skies for the fourth time on June 5, with the primary objective of evaluating the second stage’s reusable heat shield as the…

SpaceX sent Starship to orbit — the next launch will try to bring it back

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion,…

Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus

TechCrunch Disrupt showcases cutting-edge technology and innovation, and this year’s edition will not disappoint. Among thousands of insightful breakout session submissions for this year’s Audience Choice program, five breakout sessions…

You’ve spoken! Meet the Disrupt 2024 breakout session audience choice winners

Check Point is the latest security vendor to fix a vulnerability in its technology, which it sells to companies to protect their networks.

Zero-day flaw in Check Point VPNs is ‘extremely easy’ to exploit

Though Spotify never shared official numbers, it’s likely that Car Thing underperformed or was just not worth continued investment in today’s tighter economic market.

Spotify offers Car Thing refunds as it faces lawsuit over bricking the streaming device

The studies, by researchers at MIT, Ben-Gurion University, Cambridge and Northeastern, were independently conducted but complement each other well.

Misinformation works, and a handful of social ‘supersharers’ sent 80% of it in 2020

Welcome back to TechCrunch Mobility — your central hub for news and insights on the future of transportation. Sign up here for free — just click TechCrunch Mobility! Okay, okay…

Tesla shareholder sweepstakes and EV layoffs hit Lucid and Fisker

In a series of posts on X on Thursday, Paul Graham, the co-founder of startup accelerator Y Combinator, brushed off claims that OpenAI CEO Sam Altman was pressured to resign…

Paul Graham claims Sam Altman wasn’t fired from Y Combinator

In its three-year history, EthonAI has amassed some fairly high-profile customers including Siemens and chocolate-maker Lindt.

AI manufacturing startup funding is on a tear as Switzerland’s EthonAI raises $16.5M

Don’t miss out: TechCrunch Disrupt early-bird pricing ends in 48 hours! The countdown is on! With only 48 hours left, the early-bird pricing for TechCrunch Disrupt 2024 will end on…

Ticktock! 48 hours left to nab your early-bird tickets for Disrupt 2024

Biotech startup Valar Labs has built a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients.

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M

Archer Aviation is partnering with ride-hailing and parking company Kakao Mobility to bring electric air taxi flights to South Korea starting in 2026, if the company can get its aircraft…

Archer, Kakao Mobility partner to bring electric air taxis to South Korea in 2026

Space startup Basalt Technologies started in a shed behind a Los Angeles dentist’s office, but things have escalated quickly: Soon it will try to “hack” a derelict satellite and install…

Basalt plans to ‘hack’ a defunct satellite to install its space-specific OS

As a teen model, Katrin Kaurov became financially independent at a young age. Aleksandra Medina, whom she met at NYU Abu Dhabi, also learned to manage money early on. The…

Former teen model co-created app Frich to help Gen Z be more realistic about finances

Can AI help you tell your story? That’s the idea behind a startup called Autobiographer, which leverages AI technology to engage users in meaningful conversations about the events in their…

Autobiographer’s app uses AI to help you tell your life story

AI-powered summaries of web pages are a feature that you will find in many AI-centric tools these days. The next step for some of these tools is to prepare detailed…

Perplexity AI’s new feature will turn your searches into shareable pages

ChatGPT, OpenAI’s text-generating AI chatbot, has taken the world by storm. What started as a tool to hyper-charge productivity through writing essays and code with short text prompts has evolved…

ChatGPT: Everything you need to know about the AI-powered chatbot

Battery recycling startups have emerged in Europe in a bid to tap into the next big opportunity in the EV market: battery waste.  Among them is Cylib, a German-based startup…

Cylib wants to own EV battery recycling in Europe

Amazon has received approval from the U.S. Federal Aviation Administration (FAA) to fly its delivery drones longer distances, the company announced on Thursday. Amazon says it can now expand its…

Amazon gets FAA approval to expand US drone deliveries

With Plannin, creators can tell their audience about their latest trip, which hotels they liked and post photos of their travels.

Former Priceline execs debut Plannin, a booking platform that uses travel influencers to help plan trips

Amazon is rolling out its AI voice search feature to Alexa, which lets it answer open-ended questions about content.

Amazon is rolling out AI voice search to Fire TV devices

Redpanda has already integrated Benthos into its own service and has made it the core technology of its new Redpanda Connect service.

Redpanda acquires Benthos to expand its end-to-end streaming data platform

It’s a lofty goal to take on legacy payments infrastructure, however, Forward’s model has an advantage by shifting the economics back to SaaS companies.

Fintech startup Forward grabs $16M to take on Stripe, lead future of integrated payments

Fertility remains a pressing concern around the world — birthrates are down in many countries, and infertility rates (that is, the inability to conceive) are up. Rhea, a Singapore- and…

Rhea reaps $10M more led by Thiel

Microsoft, Meta, Intel, AMD and others have formed a new group to design next-gen interconnects for AI accelerator hardware.

Tech giants form an industry group to help develop next-gen AI chip components

With JioFinance, the Indian tycoon Mukesh Ambani is making his boldest consumer-facing move yet into financial services.

Ambani’s Reliance fires opening salvo in fintech battle, launches JioFinance app

Salespeople live and die by commissions. It’s no surprise, then, that Salesforce paid a premium to buy a platform that simplifies managing commissions.

Filing shows Salesforce paid $419M to buy Spiff in February

YoLa Fresh works with over a thousand retailers across Morocco and records up to $1 million in gross merchandise volume.

YoLa Fresh, a GrubMarket for Morocco, digs up $7M to connect farmers with food sellers

Instagram is expanding the scope of its “Limits” tool specifically for teenagers that would let them restrict unwanted interactions with people.

Instagram now lets teens limit interactions to their ‘Close Friends’ group to combat harassment